Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Wedbush Analyst Recommends Holding Super Micro Computer Stock

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Information Technology Stock Market Today
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

On January 19, 2024, Wedbush analyst Matt Bryson expressed his stance on Super Micro Computer (NASDAQ: SMCI), reiterating a Neutral rating and affirming a price target of $250. Rather than advocating for buying or selling the stock, Bryson advises holding onto it. His price target implies that he perceives the stock to be reasonably valued at that particular level. It is crucial to evaluate this insight in relation to your personal investment objectives and tolerance for risk.

SMCI Stock Analysis: Positive Momentum Despite Recent Drop – Investors Should Monitor Pre-Market Rise

On January 19, 2024, SMCI stock displayed some interesting price movements. According to data sourced from CNN Money, SMCI was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock was exhibiting positive price momentum.

However, the price of SMCI shares experienced a decline of $6.79 since the market last closed, representing a drop of 2.13%. The stock had closed at $311.44.

Despite this drop, there was some positive news in pre-market trading, as the stock managed to rise by $31.57.

Investors should closely monitor SMCI’s stock performance in the upcoming trading session to see if the pre-market rise can be sustained. It will be important to assess whether this increase is a temporary fluctuation or a sign of a potential upward trend.

As always, it is crucial for investors to conduct thorough research and analysis before making any investment decisions. Factors such as the company’s financial health, industry trends, and overall market conditions should all be taken into consideration.

SMCI Stock Shows Impressive Growth in Q1 2024: Total Revenue, Net Income, and EPS Soar

SMCI Stock Shows Strong Performance in Q1 2024

On January 19, 2024, SMCI stock demonstrated a solid performance, driven by its impressive financial results for the past year and first quarter. The data, sourced from CNN Money, highlights the company’s remarkable growth in total revenue, net income, and earnings per share.

Starting with total revenue, SMCI reported a significant increase of 37.09% over the past year, reaching an impressive $7.12 billion. This growth demonstrates the company’s ability to expand its market presence and capture a larger share of the industry. Additionally, it is worth noting that the total revenue remained flat since the previous quarter, indicating a stable performance.

In terms of net income, SMCI showcased remarkable growth, with a 124.43% increase since last year. The company reported a net income of $640.00 million, showcasing its ability to generate substantial profits. However, there was a slight decline of 18.89% in net income since the previous quarter. Despite this decrease, the overall trend remains positive, suggesting a strong financial performance for the company.

Earnings per share (EPS) also experienced a significant increase over the past year, rising by 114.99% to reach $11.43. This growth indicates that SMCI has been successful in increasing its profitability on a per-share basis. However, there was a decline of 19.86% in EPS since the previous quarter. While this decrease may raise some concerns, it is important to consider the overall upward trend in EPS, which showcases the company’s ability to generate consistent returns for its shareholders.

Overall, SMCI’s stock performance on January 19, 2024, was impressive, reflecting the company’s strong financial performance. The significant growth in total revenue, net income, and earnings per share over the past year demonstrates SMCI’s ability to thrive in the market. Despite a slight decline in net income and EPS since the previous quarter, the overall trend remains positive, indicating a promising future for SMCI and its shareholders.

Tags: SMCI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ projections

Goldman Sachs Analyst Maintains Buy Rating on Discover Financial Services with Adjusted Price Target

Finance_ Stock Trading (2)

Goldman Sachs Analyst Maintains Neutral Rating for Booking Holdings with Increased Price Target

Biotechnology Stock Bull Market

Decrease in Short Interest Indicates a Shift in Market Sentiment for Kyndryl Hldgs

Recommended

The Trade Desk Stock

The Trade Desk: Market Contrarians See Opportunity in Plunge

2 months ago
Kraft Heinz Stock

Kraft Heinz Split Draws Rare Public Rebuke from Frustrated Buffett

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Face Sustained Selling Pressure

5 months ago
Diginex Stock

Diginex Shares Under Pressure as Investor Confidence Wanes

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

Trending

Exxon Mobil Stock
Analysis

Exxon Mobil Charts a New Course with Major Carbon Capture Initiative

by Andreas Sommer
February 5, 2026
0

Exxon Mobil is accelerating its strategic pivot, bolstering its portfolio with significant investments in low-carbon energy solutions....

CrowdStrike Stock

CrowdStrike Shares Face Headwinds Amid Mixed Signals

February 5, 2026
NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026
Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Exxon Mobil Charts a New Course with Major Carbon Capture Initiative
  • CrowdStrike Shares Face Headwinds Amid Mixed Signals
  • NCR Voyix Charts a Course Toward Cloud-Centric Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com